Pioglitazone improves deficits of Fmr1-KO mouse model of Fragile X syndrome by interfering with excessive diacylglycerol signaling

Added 439 days ago (23.09.2020)
Authors: Geoffroy, A., Habbas, K., Zambo, B., Schramm, L., Duchon, A., Flatter, E., Fouillen, L., Zumsteg, J., Heintz, D., Mandel, J.-L., Herault, Y., Moine, H.
Source: bioRxiv
Read article